Natalizumab Therapy for Highly Active Pediatric Multiple Sclerosis
Barbara Kornek, MD, Fahmy Aboul-Enein, MD, Kevin Rostasy, MD, Ruxandra-Iulia Milos, MD, Irene Steiner, MSc, Johann Penzien, MD, Kerstin Hellwig, MD, Kalliopi Pitarokoili, MD, Karin Storm van's Gravesande, MD, Michael Karenfort, MD, Astrid Blaschek, MD, Andreas Meyer, MD, Rainer Seidl, MD, Diana Debelic, MD, Karl Vass, MD, Daniela Prayer, MD, Wolfgang Kristoferitsch, MD, Antonios Bayas, MD.
JAMA Neurol. 2013;70(4):469-475.
Published online April 1, 2013
Select Pricing Criteria: